<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">6344</item><item key="factors"><item><item key="GSM662788"><item key="CELL SOURCE">Idiotype-specific TCR-transgenic SCID mice injected with MOPC315-containing Matrigel</item><item key="CELL PHENOTYPE">tumoricidal</item></item></item><item><item key="GSM662788"><item key="CELL SOURCE">Idiotype-specific TCR-transgenic SCID mice injected with MOPC315-containing Matrigel</item><item key="CELL PHENOTYPE">tumoricidal</item></item></item><item><item key="GSM662788"><item key="CELL SOURCE">Idiotype-specific TCR-transgenic SCID mice injected with MOPC315-containing Matrigel</item><item key="CELL PHENOTYPE">tumoricidal</item></item></item><item><item key="GSM66279"><item key="CELL SOURCE">TCR-transgenic SCID mice injected with Matrigel containing antigen-loss MOPC315</item><item key="CELL PHENOTYPE">non-tumoricidal</item></item></item><item><item key="GSM66279"><item key="CELL SOURCE">TCR-transgenic SCID mice injected with Matrigel containing antigen-loss MOPC315</item><item key="CELL PHENOTYPE">non-tumoricidal</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">6</item><item key="summary_wrapped">The immune system can both promote and suppress cancer. Chronic inflammation and proinflammatory cytokines such as interleukin (IL)-1 and...</item><item key="pubmed_id">21407206</item><item key="geo_gse_id">E-GEOD-26912</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">5</item><item key="tags"><item>b-cell lymphoma</item><item>cancer</item><item>cell</item><item>immune system</item><item>interleukin</item><item>lymphoma</item><item>myeloma</item><item>scid</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">inflammation-driven-by-tumor-specific-th1-cells-pr</item><item key="geo_id_plat">E-GEOD-26912_A-AFFY-45</item><item key="name">Inflammation driven by tumor-specific Th1 cells protects against B-cell cancer</item><item key="created">Nov.11, 2014</item><item key="summary">The immune system can both promote and suppress cancer. Chronic inflammation and proinflammatory cytokines such as interleukin (IL)-1 and IL-6 are considered tumor-promoting. In contrast, the exact nature of protective antitumor immunity remains obscure. In this study, we have quantified locally secreted cytokines during primary immune responses against myeloma and B-cell lymphoma in mice. Strikingly, successful cancer immunosurveillance mediated by tumor-specific CD4+ T cells was consistently associated with elevated local levels of both proinflammatory (IL-1aplha, IL-1beta, and IL-6) and T helper 1 (Th1)-associated cytokines (interferon-alpha, IL-2, IL-12). Cancer eradication was achieved by a collaboration between tumor-specific Th1 cells and tumor-infiltrating, antigen-presenting macrophages. Th1 cells induced secretion of IL-1? and IL-6 by macrophages. Th1-derived interferon-? was shown to render macrophages directly cytotoxic to cancer cells, and to induce macrophages to secrete the angiostatic chemokines CXCL9/MIG and CXCL10/IP-10. Thus, inflammation, when driven by tumor-specific Th1 cells, may prevent rather than promote cancer. Tumoricidal macrophages were isolated from Idiotype-specific TCR-transgenic SCID mice injected with MOPC315-containing Matrigel. Control macrophages were obtained from TCR-transgenic SCID mice injected with Matrigel containing antigen-loss MOPC315.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-26912</item><item key="species">mouse</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-26912/samples/</item></data></biogps>
